The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: An independent, multicenter validation study
Abstract
BACKGROUND: A role for the serine to phenylalanine substitution at codon 45 (the S45F mutation) in the catenin (cadherin‐associated protein) β‐1 (CTNNB1) gene as a molecular predictor of local recurrence in patients with primary, sporadic desmoid tumor (DT) has been reported. To confirm the previous data, the authors evaluated the correlation between CTNNB1 mutation type and local recurrence in this multi‐institutional, retrospective study. METHODS: Patients with primary, sporadic DT who underwent macroscopic complete surgical resection were included. Recurrence‐free survival (RFS) analyses were conducted using the Kaplan‐Meier method and log‐rank tests to compare strata. RESULTS: In total, 179 patients were identified, including 65% females and 35% males (median age, 39 years; median tumor size, 7 cm). Most DTs were located in the abdominal/chest wall (42%) followed by extra‐abdominal sites (40%) and intra‐abdominal sites (18%). All patients underwent either R0 resection (62%) or R1 resection (38%), and most underwent surgery alone (80%). The tyrosine to alanine substitution at codon 41 (T41A) was the most frequent mutation (45%), but the S45F mutation was more prevalent in extra‐abdominal DTs compared with other sites (P < .001). At a median follow‐up of 50 months, 86% of patients remained alive without disease. The estimated 3‐year and 5‐year RFS rates were 0.49 and 0.45, respectively, for patients who had tumors with the S45F mutation; 0.91 and 0.91, respectively, for patients who had wild‐type tumors; and 0.70 and 0.66, respectively, for all others (P < .001). A similar trend was observed for patients who underwent surgery alone (P < .001). On multivariable analysis, mutation remained the only factor that was prognostic for local recurrence. CONCLUSIONS: This series confirmed that primary, completely resected, sporadic DTs with the S45F mutation have a greater tendency for local recurrence. With increasing implementation of “watchful‐waiting” for DT management, it will be important to determine whether mutation type predicts outcome for these patients. Cancer 2013;119:3692–3702. © 2013 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
β-catenin: a key mediator of Wnt signaling
Willert, K., & Nusse, R. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80068-3 · Cited by 753
Cited by
Kasper, B., Baumgarten, C., Garcia, J., Bonvalot, S., Haas, R., Haller, F., Hohenberger, P., Penel, N., Messiou, C., van der Graaf, W. T., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx323 · Cited by 422
Self-citationGalateau-Salle, F., Churg, A., Roggli, V., & Travis, W. D. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2015.11.005 · Cited by 282
Cavallini, A., Rotelli, M. T., Lippolis, C., Piscitelli, D., Digennaro, R., Covelli, C., Carella, N., Accetturo, M., & Altomare, D. F. (2017) · Oncotarget · doi:10.18632/oncotarget.16383 · Cited by 17
Metadata
- Authors
- Colombo, C., Miceli, R., Lazar, A. J., Perrone, F., Pollock, R. E., Le Cesne, A., Hartgrink, H. H., Cleton‐Jansen, A., Domont, J., Bovée, J. V. M. G., Bonvalot, S., Lev, D., & Gronchi, A.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2013-07-31
- Volume
- 119
- Issue
- 20
- Pages
- 3696-3702
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1602160127
- Cited by
- 184
- References
- 1
- FWCI
- 11.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.